PA8541201A1 - Glicina, n-[n-l-gamma-glutamil-3-(nitrosotio)-l-valil] y sus aplicaciones - Google Patents

Glicina, n-[n-l-gamma-glutamil-3-(nitrosotio)-l-valil] y sus aplicaciones

Info

Publication number
PA8541201A1
PA8541201A1 PA20028541201A PA8541201A PA8541201A1 PA 8541201 A1 PA8541201 A1 PA 8541201A1 PA 20028541201 A PA20028541201 A PA 20028541201A PA 8541201 A PA8541201 A PA 8541201A PA 8541201 A1 PA8541201 A1 PA 8541201A1
Authority
PA
Panama
Prior art keywords
nitrosotio
valil
glutamil
gamma
glycin
Prior art date
Application number
PA20028541201A
Other languages
English (en)
Inventor
Coy Francisco Pubill
Jose Repolles Moliner
Eduardo Perez-Rasilla
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of PA8541201A1 publication Critical patent/PA8541201A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A GLICINA, N-[N-L-GAMMA-GLUTAMIL-3-(NITROSOTIO)-L-VALIL] DE LA SIGUIENTE FORMULA (I): Y A SUS SALES FISIOLOGICAMENTE ACEPTABLES, ASI COMO A PRODUCTOS FARMACEUTICOS QUE CONTIENEN UNO O VARIOS DE ESTOS COMPUESTOS, A LOS METODOS DE TRATAMIENTO Y PREVENCION DE ENFERMEDADES, INCLUSIVE LA ADMINISTRACION DE UNA CANTIDAD EFICAZ DE UNO O VARIOS DE DICHOS COMPUESTOS Y A LA UTILIZACION DE UNO O VARIOS DE DICHOS COMPUESTOS DE PRODUCCION DE UN MEDICAMENTO PARA EL TRATAMIENTO Y LA PREVENCION DE ENFERMEDADES.
PA20028541201A 2001-03-13 2002-03-12 Glicina, n-[n-l-gamma-glutamil-3-(nitrosotio)-l-valil] y sus aplicaciones PA8541201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200100577A ES2173044B1 (es) 2001-03-13 2001-03-13 Derivados de glicina, n-(n-l-gamma-glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.

Publications (1)

Publication Number Publication Date
PA8541201A1 true PA8541201A1 (es) 2003-02-28

Family

ID=8497059

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20028541201A PA8541201A1 (es) 2001-03-13 2002-03-12 Glicina, n-[n-l-gamma-glutamil-3-(nitrosotio)-l-valil] y sus aplicaciones

Country Status (5)

Country Link
AU (1) AU2002310939A1 (es)
ES (1) ES2173044B1 (es)
PA (1) PA8541201A1 (es)
PE (1) PE20021040A1 (es)
WO (1) WO2002085847A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69008454T2 (de) * 1989-08-07 1994-08-25 Takeda Chemical Industries Ltd Nitrolsothiolderivate, ihre Herstellung und Verwendung.
ES2147162B1 (es) * 1999-01-27 2001-03-16 Lacer Sa "s-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias".

Also Published As

Publication number Publication date
WO2002085847A2 (en) 2002-10-31
PE20021040A1 (es) 2002-11-19
ES2173044B1 (es) 2004-01-16
ES2173044A1 (es) 2002-10-01
AU2002310939A1 (en) 2002-11-05
WO2002085847A3 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
ES2144623T3 (es) Heterociclos diaril biciclicos como inhibidores de la ciclooxigenasa-2.
MX2021006421A (es) Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
PA8547701A1 (es) Nucleosidos 4 substituidos.
SE0200979D0 (sv) New compounds
BR0312729A (pt) Novos derivados de indol-3-enxofre
NO20055590L (no) Kinaseinhiberende fosfonatanaloger
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
GT200300107A (es) Tratamiento y prevencion de la osteoporosis
CO5590918A2 (es) Formulaciones
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
CO2021005070A2 (es) Inhibición de la proteasa 30 específica de la ubiquitina (usp30)
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
ES2038172T3 (es) Procedimiento para preparar carboxamidas heterociclicas.
BRPI0410044A (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
ATE371724T1 (de) Behandlung neurodegenerativer krankheiten
PE20021016A1 (es) Conjugados de pregabalina-lactosa
HUP0302970A2 (hu) Aminosavak felhasználása fájdalom kezelésére, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
PA8541201A1 (es) Glicina, n-[n-l-gamma-glutamil-3-(nitrosotio)-l-valil] y sus aplicaciones
RS52507B (en) APPLICATION OF SPECIFIC HISTONS FOR THE TREATMENT OF PARASITIC DISEASES
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
BR0112690A (pt) Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos